Willow vs HumeCare+ — structured follow-up vs bundled protocol

Quick verdict: Willow centers on a telehealth-first oral GLP-1 program that emphasizes progress tracking and follow-up support, while HumeCare+ bundles compounded semaglutide or tirzepatide with glycine and B vitamins plus body-composition scans and a 10%-or-money-back promise. For structured behavioral follow-up choose Willow; for a bundled muscle-preserving protocol and lean-mass tracking choose HumeCare+.

Explore Willow’s tracked program

How the programs differ at a glance: Willow vs HumeCare+

Both vendors place treatment behind clinician review and may offer compounded medications; the regulatory note for both is that compounded medications are not FDA-evaluated for safety, quality, or efficacy. The table below highlights the most distinctive supported differences between Willow and HumeCare+.

Criterion	Willow	HumeCare+
Core offering	Oral GLP-1 program framed as a structured weight management journey with progress tracking and follow-up support	Protocol combining physician-prescribed compounded semaglutide or tirzepatide with glycine and B vitamins
Starting price	Starting at $299	Semaglutide from $199/mo; tirzepatide protocol from $299/mo
Support tools	Progress tracking tools and follow-up consultations via a licensed telehealth team	Body-composition scans, app for tracking, and 24/7 clinician access
Protocol extras	Focus on behavioral scaffolding and follow-up; described as not just a medication subscription	Glycine plus B6 and B12 included to support muscle and side-effect relief
Guarantees and cancellations	Not verified on captured page	10%-or-money-back promise over six months (terms apply); cancel anytime
Regulatory note	Treatment only when a licensed clinician determines it is medically appropriate; compounded meds not FDA-approved when offered	Treatment only when a licensed clinician determines it is medically appropriate; compounded medications are not evaluated by the FDA

Distinctive difference 1: Program focus and follow-up

Willow positions its oral GLP-1 program as a structured weight management journey rather than a medication subscription, emphasizing progress tracking and follow-up consultations delivered by a licensed telehealth team. HumeCare+ instead markets a bundled protocol that pairs medication with supportive ingredients and continuous physician optimization, plus an app and body-composition scans. Both require a licensed clinician to determine medical appropriateness.

See HumeCare+ protocol details

Distinctive difference 2: What is added to the medication

Willow highlights behavioral scaffolding and follow-up support as the primary add-on to medication. HumeCare+ explicitly adds glycine and vitamins B6 and B12 to its compounded GLP-1 formulations, positioning these ingredients for sleep, muscle protection, recovery, and mitigation of nausea or low energy. HumeCare+ also offers a choice of semaglutide or dual-action tirzepatide within its protocol.

Compare Willow support features

Distinctive difference 3: Tracking lean mass vs overall progress

HumeCare+ includes monthly body-composition scans to track lean mass versus fat, a capability the provider cites as addressing a known GLP-1 limitation. Willow focuses on wellness tracking and follow-up consultations but the captured evidence emphasizes progress tracking rather than monthly body-composition scans.

Pricing, promises, and limitations

Published starting prices differ: Willow lists a starting price of $299, while HumeCare+ lists semaglutide from $199/month and a tirzepatide protocol from $299/month. HumeCare+ advertises a 10%-or-money-back promise over six months with terms to verify. Both providers state treatment is available only when a licensed clinician determines it is medically appropriate, and both note that compounded medications are not FDA-evaluated for safety, effectiveness, or quality when offered.

Review HumeCare+ pricing and promise

Safety and regulatory note

Both sources state that treatment is available only when a licensed clinician determines it is medically appropriate. Each source includes a regulatory note that compounded medications, when offered, are not FDA-evaluated for safety, effectiveness, or quality. HumeCare+ additionally calls attention to known serious risks of GLP-1 drugs in its captured cons summary.

Final comparison and who should choose which

Willow vs HumeCare+: Willow emphasizes a telehealth-first oral GLP-1 program with progress tracking and structured follow-up to convert medication effect into long-term behavior change. HumeCare+ offers a bundled protocol with compounded semaglutide or tirzepatide plus glycine and B vitamins, body-composition scans, a connected app, and a 10%-or-money-back promise for eligible enrollees.

Start with Willow’s tracked approach

Choose Willow if you want a telehealth-first program that prioritizes progress tracking, follow-up consultations, and behavioral support paired with oral GLP-1 treatment when a licensed clinician approves it. Choose HumeCare+ if you want a bundled, muscle-preserving protocol with glycine and B vitamins, monthly body-composition scans, a dedicated app, choice of semaglutide or tirzepatide, and a 10%-or-money-back promise subject to terms.